Home > > > Advanced Diagnostic Solutions Boosting the Food Allergy Market

Advanced Diagnostic Solutions Boosting the Food Allergy Market

Author : savi ssd | Published On : 19 Jun 2026

The global food allergy market is experiencing steady growth due to the rising prevalence of food allergies worldwide, increasing awareness regarding allergy diagnosis and management, growing demand for allergy therapeutics, and advancements in immunotherapy treatments. The global food allergy market size was valued at USD 40.14 billion in 2025 and is projected to grow from USD 42.27 billion in 2026 to USD 63.89 billion by 2034, registering a CAGR of 5.3% during the forecast period (2026–2034).

Food allergy is an immune system reaction that occurs when the body mistakenly identifies certain food proteins as harmful substances. Common food allergens include peanuts, tree nuts, milk, eggs, soy, wheat, fish, and shellfish. Food allergies can range from mild symptoms to severe and potentially life-threatening reactions such as anaphylaxis, creating a growing need for effective diagnosis, treatment, and management solutions.

Market Drivers

Rising Prevalence of Food Allergies

The increasing incidence of food allergies among children and adults worldwide is driving demand for diagnostic tests, emergency treatments, and allergy management products.

Growing Awareness and Early Diagnosis

Public health campaigns, educational initiatives, and improved access to healthcare services are encouraging early detection and proper management of food allergies.

Advancements in Immunotherapy Treatments

Innovations in oral immunotherapy, epicutaneous immunotherapy, and biologic therapies are creating new opportunities for long-term food allergy treatment.

Increasing Demand for Allergy Testing

Healthcare providers are increasingly utilizing advanced diagnostic tools such as skin prick tests, blood tests, and molecular diagnostics to improve diagnostic accuracy.

Expansion of Specialty Healthcare Services

The growing availability of allergy clinics, specialized healthcare centers, and telemedicine services is supporting market growth.

For Detailed Insights, Visit:

https://straitsresearch.com/report/food-allergy-market

Market Challenges

High Treatment Costs

Advanced allergy therapies and biologic treatments can be expensive, limiting accessibility for some patient populations.

Lack of Permanent Cure

Although several treatment options help manage symptoms, a permanent cure for most food allergies remains unavailable.

Risk of Severe Allergic Reactions

Patients undergoing immunotherapy may experience adverse reactions that require careful medical supervision.

Limited Awareness in Developing Regions

Insufficient healthcare access and low awareness levels in certain regions may hinder diagnosis and treatment adoption.

Market Segmentation

The food allergy market is segmented based on allergen type, diagnosis, treatment, end user, and region.

By Allergen Type

The market is categorized into:

  • Peanut Allergy

  • Tree Nut Allergy

  • Milk Allergy

  • Egg Allergy

  • Soy Allergy

  • Wheat Allergy

  • Fish Allergy

  • Shellfish Allergy

  • Others

Peanut allergy accounts for a significant market share due to its high prevalence and potential for severe allergic reactions.

By Diagnosis

The market includes:

  • Skin Prick Test

  • Blood Test

  • Oral Food Challenge

  • Patch Test

  • Molecular Diagnostics

Skin prick testing remains one of the most widely used diagnostic methods due to its effectiveness and accessibility.

By Treatment

The market is segmented into:

  • Antihistamines

  • Epinephrine Auto-Injectors

  • Oral Immunotherapy

  • Biologic Therapies

  • Avoidance Management

Epinephrine auto-injectors represent a major treatment segment due to their critical role in managing severe allergic reactions.

By End User

The market includes:

  • Hospitals

  • Specialty Allergy Clinics

  • Diagnostic Centers

  • Home Care Settings

Specialty allergy clinics account for a substantial market share due to increasing demand for specialized diagnosis and treatment services.

By Region

The market is analyzed across:

  • North America

  • Europe

  • Asia-Pacific

  • Latin America

  • Middle East & Africa

Regional Insights

North America

North America dominates the food allergy market due to high allergy prevalence rates, advanced healthcare infrastructure, strong awareness programs, and increasing adoption of innovative therapies.

Europe

Europe holds a significant market share supported by growing healthcare investments, increasing allergy research initiatives, and favorable regulatory frameworks.

Asia-Pacific

Asia-Pacific is expected to witness the fastest growth due to rising allergy awareness, improving healthcare infrastructure, growing urbanization, and increasing diagnosis rates across China, India, Japan, and South Korea.

Latin America

Latin America is experiencing steady growth due to expanding healthcare access and increasing awareness regarding allergic disorders.

Middle East & Africa

The region is witnessing gradual growth driven by healthcare modernization efforts and rising awareness of food allergy management.

Technology Trends and Market Opportunities

The food allergy market is evolving through innovations in biologic therapies, precision medicine, molecular diagnostics, wearable allergy monitoring devices, and artificial intelligence-powered allergy management platforms. Researchers are increasingly focusing on developing disease-modifying therapies that address the root causes of allergic reactions.

Growing investments in immunotherapy research, personalized treatment approaches, digital healthcare platforms, and preventive allergy management programs are creating substantial opportunities for market participants. Furthermore, increasing regulatory approvals for novel allergy therapies are expected to support long-term market growth.

Key Players Analysis

The food allergy market is highly competitive, with major companies focusing on research and development, clinical trials, strategic partnerships, and innovative therapeutic solutions.

Major companies operating in the market include:

  • Stallergenes Greer

  • ALK-Abelló A/S

  • DBV Technologies S.A.

  • Aimmune Therapeutics, Inc.

  • Sanofi S.A.

  • Regeneron Pharmaceuticals, Inc.

  • Thermo Fisher Scientific Inc.

  • Siemens Healthineers AG

  • Danaher Corporation

  • F. Hoffmann-La Roche Ltd.

These companies continue to invest in innovative immunotherapy solutions, advanced diagnostic technologies, biologic treatments, and personalized allergy management strategies to strengthen their positions in the global food allergy market.

Related Report

Allergy Diagnostics Market

https://straitsresearch.com/report/allergy-diagnostics-market

About Us

Straits Research is a leading market research and intelligence organization specializing in analytics, advisory services, and comprehensive market research reports across multiple industries.

Contact Us

Email: [email protected]

U.S. Tel: +1 646 905 0080

U.K. Tel: +44 203 695 0070